171 related articles for article (PubMed ID: 35730249)
21. Discovery of Novel Pleuromutilin Derivatives as Potent Antibacterial Agents for the Treatment of MRSA Infection.
Fang HQ; Zeng J; Wang SK; Wang X; Chen F; Li B; Liu J; Jin Z; Liu YH; Tang YZ
Molecules; 2022 Jan; 27(3):. PubMed ID: 35164203
[TBL] [Abstract][Full Text] [Related]
22. Design, synthesis, and antibacterial activity of novel pleuromutilin derivatives bearing an amino thiazolyl ring.
Ling Y; Wang X; Wang H; Yu J; Tang J; Wang D; Chen G; Huang J; Li Y; Zheng H
Arch Pharm (Weinheim); 2012 Aug; 345(8):638-46. PubMed ID: 22532317
[TBL] [Abstract][Full Text] [Related]
23. Design, synthesis and biological evaluation of pleuromutilin-Schiff base hybrids as potent anti-MRSA agents in vitro and in vivo.
Li B; Zhang Z; Zhang JF; Liu J; Zuo XY; Chen F; Zhang GY; Fang HQ; Jin Z; Tang YZ
Eur J Med Chem; 2021 Nov; 223():113624. PubMed ID: 34153574
[TBL] [Abstract][Full Text] [Related]
24. Design, synthesis, and antibacterial activity of pleuromutilin derivatives.
Liu HX; Yao WY; Cui G; Zhou J; Yan H; Guo H; Wang YW; Zhang Y
Chem Biol Drug Des; 2024 Jun; 103(6):e14554. PubMed ID: 38806405
[TBL] [Abstract][Full Text] [Related]
25. Synthesis and antibacterial activities of novel pleuromutilin derivatives bearing an aminothiophenol moiety.
Zhang ZS; Huang YZ; Luo J; Jin Z; Liu YH; Tang YZ
Chem Biol Drug Des; 2018 Sep; 92(3):1627-1637. PubMed ID: 29722184
[TBL] [Abstract][Full Text] [Related]
26. Antibacterial activity evaluation of pleuromutilin derivatives with 4(3H)-quinazolinone scaffold against methicillin-resistant Staphylococcusaureus.
Deng Y; Zhang Y; Chen XH; Li CH
Eur J Med Chem; 2023 Jan; 246():114960. PubMed ID: 36462445
[TBL] [Abstract][Full Text] [Related]
27. Design, synthesis and biological evaluation of novel pleuromutilin derivatives possessing acetamine phenyl linker.
Jin Z; Wang L; Gao H; Zhou YH; Liu YH; Tang YZ
Eur J Med Chem; 2019 Nov; 181():111594. PubMed ID: 31419741
[TBL] [Abstract][Full Text] [Related]
28. Novel pleuromutilin derivatives as antibacterial agents: synthesis, biological evaluation and molecular docking studies.
Wang X; Ling Y; Wang H; Yu J; Tang J; Zheng H; Zhao X; Wang D; Chen G; Qiu W; Tao J
Bioorg Med Chem Lett; 2012 Oct; 22(19):6166-72. PubMed ID: 22932314
[TBL] [Abstract][Full Text] [Related]
29. Synthesis and antibacterial activities of novel pleuromutilin derivatives.
Yi Y; Fu Y; Wang K; Shui Y; Cai J; Jia Z; Niu B; Liang J; Shang R
Arch Pharm (Weinheim); 2018 Sep; 351(9):e1800155. PubMed ID: 30058185
[TBL] [Abstract][Full Text] [Related]
30. Design, synthesis, biological evaluation and molecular docking study of novel pleuromutilin derivatives containing substituted benzoxazole as antibacterial agents.
Ren J; Zhang QW; He XJ; Chen XY; Zhou ZD; Zeng ZL; Jin Z; Tang YZ
J Enzyme Inhib Med Chem; 2023 Dec; 38(1):2251712. PubMed ID: 37664987
[TBL] [Abstract][Full Text] [Related]
31. Synthesis and Pharmacological Evaluation of Novel Pleuromutilin Derivatives with Substituted Benzimidazole Moieties.
Ai X; Pu X; Yi Y; Liu Y; Xu S; Liang J; Shang R
Molecules; 2016 Nov; 21(11):. PubMed ID: 27834819
[TBL] [Abstract][Full Text] [Related]
32. Design, synthesis and biological activities of novel pleuromutilin derivatives with a substituted triazole moiety as potent antibacterial agents.
Zhang Z; Li K; Zhang GY; Tang YZ; Jin Z
Eur J Med Chem; 2020 Oct; 204():112604. PubMed ID: 32731187
[TBL] [Abstract][Full Text] [Related]
33. Synthesis, biological activities, and docking study of novel chalcone-pleuromutilin derivatives.
Xie C; Zhang S; Zhang W; Wu C; Yong C; Sun Y; Zeng Z; Zhang Q; Huang Z; Chen T; Zhang Y
Chem Biol Drug Des; 2020 Aug; 96(2):836-849. PubMed ID: 32271987
[TBL] [Abstract][Full Text] [Related]
34. Design, synthesis and antibacterial evaluation of pleuromutilin derivatives.
Wu G; Zhu Z; Li J; Luo X; Zhu W; Liao G; Xia J; Zhang W; Pan W; Li T; Wu S
Bioorg Med Chem; 2022 Apr; 59():116676. PubMed ID: 35220163
[TBL] [Abstract][Full Text] [Related]
35. Design, synthesis, and biological activity evaluation of a series of pleuromutilin derivatives with novel C14 side chains.
Li YG; Wang JX; Zhang GN; Zhu M; You XF; Wang YC; Zhang F
Bioorg Med Chem Lett; 2020 Apr; 30(7):126969. PubMed ID: 32014384
[TBL] [Abstract][Full Text] [Related]
36. Novel pyridinium cationic pleuromutilin analogues overcoming bacterial multidrug resistance.
Yi Y; Zhang J; Zuo J; Zhang M; Yang S; Huang Z; Li G; Shang R; Lin S
Eur J Med Chem; 2023 May; 251():115269. PubMed ID: 36924667
[TBL] [Abstract][Full Text] [Related]
37. Synthesis, biological activities and docking studies of pleuromutilin derivatives with piperazinyl urea linkage.
Zhang Y; Xie C; Liu Y; Shang F; Shao R; Yu J; Wu C; Yao X; Liu D; Wang Z
J Enzyme Inhib Med Chem; 2021 Dec; 36(1):764-775. PubMed ID: 33733986
[TBL] [Abstract][Full Text] [Related]
38. Chemical synthesis and biological activities of novel pleuromutilin derivatives with substituted amino moiety.
Shang R; Wang S; Xu X; Yi Y; Guo W; Yuliu ; Liang J
PLoS One; 2013; 8(12):e82595. PubMed ID: 24376551
[TBL] [Abstract][Full Text] [Related]
39. Novel pleuromutilin derivatives with substituted 6-methylpyrimidine: Design, synthesis and antibacterial evaluation.
Fan Y; Liu Y; Wang H; Shi T; Cheng F; Hao B; Yi Y; Shang R
Eur J Med Chem; 2020 Dec; 207():112735. PubMed ID: 32827940
[TBL] [Abstract][Full Text] [Related]
40. Semi-synthesis, antibacterial activity, and molecular docking study of novel pleuromutilin derivatives bearing cinnamic acids moieties.
Deng Y; Tang D; Wang QR; Huang S; Fu LZ; Li CH
Arch Pharm (Weinheim); 2019 Jan; 352(1):e1800266. PubMed ID: 30536467
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
